Research Article
Volume 13 Issue 9 - 2021
Factors Associated with HIV-Related Perceived Stigma among HIV-Positive Youths Attending ART Follow-Up in Jimma Town Public Health Facilities, Southwest Ethiopia
Derara Girma1*, Hiwot Dejene1, Leta Adugna1 and Bilisumamulifna Tefera2
1Department of Public Health, College of Health Sciences, Salale University, Fitche, Ethiopia
2Department of Public Health, College of Health Sciences, Mettu University, Mettu, Ethiopia
*Corresponding Author: Derara Girma, Department of Public Health, College of Health Sciences, Salale University, Fitche, Ethiopia.
Received: July 30, 2021; Published: August 27, 2021


Introduction: Youth living with HIV (age 15 - 24) had a higher risk of HIV-related stigma than any older age group. As well, HIV-related stigma is the main risk factor for adverse outcomes among HIV-positive youths. However, the magnitude and factors associated with perceived stigma among HIV-positive youths in Ethiopia have not been extensively quantified so far. Therefore, site-specific evidence is vital to identify factors associated with perceived stigma among HIV-positive youths.

Methods: An institution-based cross-sectional study was conducted from March 2020 to June 2020 among 341 HIV-positive youths on anti-retroviral therapy follow-up. Participants were selected using a systematic random sampling technique. Data were collected using interviewer-administered techniques and medical record review. The collected data were entered into Epi Data 3.1 and exported to SPSS version 22 for analysis. The Adjusted Odds Ratio (AOR) with 95% CI was used to measure the association along with a respective p-value < 0.05 to identify statistically significant variables in the multivariable logistic regression.

Results: A total of 325 HIV-positive youths have participated in this study with a response rate of 95.3%. The magnitude of perceived stigma among HIV-positive youths was 63.15 (95% CI: 57.2, 68.0). In multivariable analysis, rural resident (AOR = 2.55, 95%CI: 1.37 - 4.74), HIV serostatus nondisclosure (AOR = 2.84, 95%CI: 1.55 - 5.19), poor antiretroviral treatment adherence (AOR = 2.52, 95%CI: 1.18-5.38), TB co-morbid (AOR = 2.27, 95%CI: 1.04 - 4.98), and less than one year since diagnosed with HIV/AIDS (AOR = 1.90, 95%CI: 1.10 - 3.28) were factors independently associated with perceived stigma.

Conclusion: This finding confirmed that HIV-positive youths in the study area experienced a high magnitude of perceived stigma. For stigma to be declined, giving notable consideration to factors significantly associated with stigma would be beneficial.

Keywords: Stigma; HIV; Adolescent; Youth; Ethiopia


  1. Adolescent HIV prevention - UNICEF DATA [Internet] (2019).
  2. World Health Organization. WHO | HIV and youth (2017).
  3. Young people, HIV and AIDS (2018).
  4. Federal HIV/AIDS Prevention and Control Office. HIV prevention in Ethiopia National Road map: 2018-2020 (2018).
  5. HIV Stigma and Discrimination (2015).
  6. “On the Fast-Track to end AIDS by 2030: Focus on location and population (2015): 1-260.
  7. Parker R and Aggleton P. “HIV and AIDS-related stigma and discrimination: A conceptual framework and implications for action”. Social Science and Medicine1 (2003): 13-24.
  8. Deacon H. “Understanding HIV/AIDS stigma: a theoretical and methodological analysis/Library of Congress (2005).
  9. Pantelic M., et al. “Predictors of internalised HIV-related stigma: a systematic review of studies in sub-Saharan Africa”. Health Psychology Review4 (2015): 469-490.
  10. Ashaba S., et al. “Internalized HIV stigma, bullying, major depressive disorder, and high-risk suicidality among HIV-positive adolescents in rural Uganda”. Global Mental Health 5 (2018): e22.
  11. Earnshaw VA., et al. “Stigma, Depression, and Substance Use Problems Among Perinatally HIV-Infected Youth in South Africa”. AIDS and Behavior12 (2018): 3892-3896.
  12. Pantelic M., et al. “HIV, violence, blame and shame: Pathways of risk to internalized HIV stigma among South African adolescents living with HIV: Pathways”. Journal of the International AIDS Society1 (2017): 1-9.
  13. Pantelic M., et al. “Multiple forms of discrimination and internalized stigma compromise retention in HIV care among adolescents: findings from a South African cohort”. Journal of the International AIDS Society5 (2020): 1-8.
  14. Swendeman D., et al. “Predictors of HIV-related stigma among young people living with HIV”. Health Psychology Journal4 (2006): 501-509.
  15. Vreeman RC., et al. “Mental health challenges among adolescents living with HIV”. Journal of the International AIDS Society3 (2017): 100-109.
  16. Kimera E., et al. “Challenges and support for quality of life of youths living with HIV/AIDS in schools and larger community in East Africa: A systematic review”. Systematic Reviews in Pharmacy1 (2019): 1-18.
  17. Rongkavilit C., et al. “HIV stigma, disclosure and psychosocial distress among Thai youth living with HIV”. International Journal of STD and AIDS2 (2010): 126-132.
  18. Clum G., et al. “Mediators of HIV-related stigma and risk behavior in HIV infected young women”. AIDS Care - Psychol Socio-Medical Asp AIDS/HIV11 (2009): 1455-1462.
  19. Varni SE., et al. “Disengagement and engagement coping with HIV/AIDS stigma and psychological well-being of people with HIV/AIDS”. Journal of Social and Clinical Psychology2 (2012): 123-150.
  20. Earnshaw VA., et al. “Stigma, Depression, and Substance Use Problems Among Perinatally HIV-Infected Youth in South Africa”. AIDS and Behavior12 (2018): 3892-3896.
  21. Capron DW., et al. “Suicidality and anxiety sensitivity in adults with HIV”. AIDS Patient Care STDS5 (2012): 298-303.
  22. Fortenberry JD., et al. “Linkage to Care for HIV-Positive Adolescents: A Multisite Study of the Adolescent Medicine Trials Units of the Adolescent Trials Network”. Journal of Adolescent Health6 (2012): 551-556.
  23. France NF., et al. “Correction: ’We are the change’-An innovative community-based response to address self-stigma: A pilot study focusing on people living with HIV in Zimbabwe”. PLoS One2 (2019): 1-24.
  24. Hightow-Weidman LB., et al. “Patterns of HIV disclosure and condom use among HIV-infected young racial/ethnic minority men who have sex with men”. AIDS and Behavior1 (2013): 360-368.
  25. Kurth AE., et al. “HIV testing and linkage to services for youth”. Journal of the International AIDS Society2 (2015): 23-28.
  26. Nabunya P., et al. “Factors Associated With HIV Disclosure and HIV-Related Stigma Among Adolescents Living With HIV in Southwestern Uganda”. Frontiers in Psychiatry 11 (2020): 1-10.
  27. Abimbola O., et al. “Psychosocial Factors of Stigma and Relationship to Healthcare Service among Adolescents Living With HIV / AIDS in Kano State, Nigeria (2020).
  28. Martinez J., et al. “The impact of stigma on medication adherence among HIV-positive adolescent and young adult females and the moderating effects of coping and satisfaction with health care”. AIDS Patient Care STDS2 (2012): 108-115.
  29. Tran BX., et al. “Understanding Global HIV Stigma and Discrimination: Are Contextual Factors Sufficiently Studied? (GAPRESEARCH)”. International Journal of Environmental Research and Public Health11 (2019): 1899.
  30. Hargreaves JR., et al. “Individual and community-level risk factors for HIV stigma in 21 Zambian and South African communities: Analysis of data from the HPTN071 (PopART) study”. Aids6 (2018): 783-793.
  31. Wodajo BS., et al. “HIV and AIDS-related stigma and discrimination in two referral hospitals in Ethiopia”. African Journal of AIDS Research2 (2017): 137-144.
  32. Adane B., et al. “Perceived Stigma and Associated Factors Among People Living with HIV Attending ART Clinics in Public Health Facilities of Dessie City, Ethiopia”. HIV/AIDS-Research Palliat Care 12 (2020): 551-557.
  33. Endeshaw M., et al. “Stigma in Ethiopia: association with depressive symptoms in people with HIV”. AIDS Care -Psychological Socio-Medical Asp AIDS/HIV8 (2014): 935-939.
  34. Neno Nikus Fido., et al. “HIV stigma and associated factors among antiretroviral treatment clients in Jimma town, Southwest Ethiopia”. HIV/AIDS-Research Palliat Care 8 (2016): 183-193.
  35. Tesfay F., et al. “Stigma and discrimination: Barriers to the utilisation of a nutritional program in HIV care services in the Tigray region, Ethiopia”. BMC Public Health1 (2020): 1-13.
  36. Mburu G., et al. “Resisting and challenging stigma in Uganda: the role of support groups of people living with HIV”. Journal of the International AIDS Society 3-2 (2013): 1-7.
  37. Wiklander M., et al. “Psychometric properties of a short version of the HIV stigma scale, adapted for children with HIV infection”. Health and Quality of Life Outcomes 1 (2013): 1-7.
  38. Abebe H., et al. “Prevalence of Depressive Symptoms and Associated Factors among HIV-Positive Youth Attending ART Follow-Up in Addis Ababa, Ethiopia”. AIDS Research and Treatment (2019).
  39. Kemigisha E., et al. “Prevalence of depressive symptoms and associated factors among adolescents living with HIV/AIDS in South Western Uganda”. AIDS Care 10 (2019): 1297-1303.
  40. Cluver L and Orkin M. “Cumulative risk and AIDS-orphanhood: Interactions of stigma, bullying and poverty on child mental health in South Africa”. Social Science and Medicine 8 (2009): 1186-1193.
  41. World Health Organization. Adolescent Mental Health (2020).
  42. Nugent C., et al. “Risk factors associated with experienced stigma among people diagnosed with mental ill-health: a cross-sectional study”. Psychiatr Q (2020).
  43. Pourmarzi D., et al. “Perceived Stigma in People Living With HIV in Qom”. Journal of Family and Reproductive Health 11 (2017).
  44. McHenry MS., et al. “HIV Stigma: Perspectives from Kenyan Child Caregivers and Adolescents Living with HIV”. Journal of the International Association of Providers of AIDS Care3 (2017): 215-225.
  45. Madiba S and Mokgatle M. “Perceptions and Experiences about Self-Disclosure of HIV Status among Adolescents with Perinatal Acquired HIV in Poor-Resourced Communities in South Africa”. AIDS Research and Treatment (2016).
  46. Duko B., et al. “Perceived Stigma and Associated Factors among Patient with Tuberculosis, Wolaita Sodo, Ethiopia: Cross-Sectional Study”. Tuberculosis Research and Treatment (2019): 1-5.
  47. Li L., et al. “Stigma, social support, and depression among people living with HIV in Thailand”. AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV8 (2009): 1007-1013.
  48. Jones HS., et al. “Association between HIV stigma and antiretroviral therapy adherence among adults living with HIV: baseline findings from the HPTN 071 (PopART) trial in Zambia and South Africa”. Tropical Medicine and International Health10 (2020): 1246-1260.
  49. Subedi B., et al. “Perceived stigma among people living with HIV/AIDS in Pokhara, Nepal”. HIV/AIDS - Research and Palliative Care 11 (2019): 93-103.
  50. Global Health Sector Strategy on HIV 2016-2021: Towards Ending AIDS. World Health Organization (2016).
Citation: Derara Girma., et al. “Factors Associated with HIV-Related Perceived Stigma among HIV-Positive Youths Attending ART Follow-Up in Jimma Town Public Health Facilities, Southwest Ethiopia”. EC Neurology 13.9 (2021): 37-47.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

November Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 15, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.